title: [Therapeutic use of a peptide fraction derived from bovine factor VIII in epistaxis in children].
abstract: The results obtained in patients suffering from essential epistaxis in paediatric age using a peptide fraction derived from the enzymatic hydrolysis of bovine factor VIII (VUEFFE-Baldacci) are reported. Carbazochrome sodium sulphate was employed for comparison purposes. Vueffe is effective in reducing haemorrhagic episodes without modifying the laboratory parameters investigated.
authors.forename: V
authors.initials: V
authors.lastname: Tarantino
authors.forename: M
authors.initials: M
authors.lastname: Stura
authors.forename: M
authors.initials: M
authors.lastname: Cingolani
mesh_terms: D000293:Adolescent; D000323:Adrenochrome / Q000031:analogs & derivatives / Q000627:therapeutic use; D002648:Child; D004341:Drug Evaluation; D004844:Epistaxis / Q000188:drug therapy*; D005169:Factor VIII / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D016032:Randomized Controlled Trials as Topic
chemical_list: D000323:Adrenochrome; C073338:carbazochrome; D005169:Factor VIII
vernacular_title: Utilizzaione terapeutica di una frazione peptidica derivata dal fattore VIII bovino nelle epistassi in età pediatrica.